44
Views
25
CrossRef citations to date
0
Altmetric
Original Article

Cyclosporin Pharmacokinetics after Intravenous and Oral Administration in Patients with Crohn's Disease

, , &
Pages 961-967 | Received 01 Mar 1992, Accepted 07 Jul 1992, Published online: 08 Jul 2009
 

Abstract

Cyclosporin kinetics were estimated after single-dose intravenous and oral administration in 12 patients with Crohn's disease in accordance with a three-compartment model with zero-order inputs. Cyclosporin was measured in whole blood with a specific monoclonal radioimmunoassay. The median bioavailability (f) was 23.7% (range, 0–49.1%); the distribution volume at steady state, 2.31/kg (range, 1.0–3.5 1/kg); clearance (CL), 7.6ml/min/kg (range, 4.8–10.8 ml/min/kg); and t1/2(z) 7.9 h (range, 3.2–13.9 h). Both the extent and rate of bioavailability were significantly lower in six of the patients, who had low or undetectable cyclosporin levels during a preceding therapeutic trial. After repeated oral administration significant correlations were found between the single-dose f/CL ratios and the steady-state blood concentrations, indicating that the kinetics did not change markedly with time. We conclude that the disposition kinetics of cyclosporin in patients with Crohn's disease are comparable to those of other groups. whereas the bioavailability may be decreased. It is suggested that cyclosporin levels should be monitored closely, and intravenous treatment should be considered in patients with a rapid gut transit time. because cyclosporin absorption seems to follow zero-order kinetics.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.